Cullen Investment Group, Ltd. Merck & Co., Inc. Transaction History
Cullen Investment Group, Ltd.
- $771 Billion
- Q4 2025
A detailed history of Cullen Investment Group, Ltd. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Cullen Investment Group, Ltd. holds 117,623 shares of MRK stock, worth $10.9 Million. This represents 1.69% of its overall portfolio holdings.
Number of Shares
117,623
Previous 129,316
9.04%
Holding current value
$10.9 Million
Previous $11.5 Billion
12.72%
% of portfolio
1.69%
Previous 1.53%
Shares
9 transactions
Others Institutions Holding MRK
# of Institutions
3,915Shares Held
1.9BCall Options Held
30.1MPut Options Held
27.7M-
Vanguard Group Inc Valley Forge, PA252MShares$23.4 Billion0.33% of portfolio
-
Black Rock Inc. New York, NY207MShares$19.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$11 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA75.3MShares$6.99 Billion1.16% of portfolio
-
Geode Capital Management, LLC Boston, MA59.8MShares$5.55 Billion0.33% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $235B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...